BRIMSON E/DROP

BRIMSON E/DROP is an ophthalmic solution containing Brimonidine Tartrate, designed to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. This alpha-2 adrenergic agonist works by decreasing aqueous humor production and increasing uveoscleral outflow, helping to protect against vision loss. Suitable for daily use, BRIMSON E/DROP provides effective pressure management with a convenient drop formulation. Each application delivers consistent dosing for reliable therapeutic outcomes. Ideal for patients seeking to maintain eye health and prevent glaucoma progression through medical management.